ALTIMMUNE, INC. Available-for-sale Securities, Gross Unrealized Loss
ALTIMMUNE, INC. (ALT) reported Available-for-sale Securities, Gross Unrealized Loss of -$1.05 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2017-05-03
- ALTIMMUNE, INC. available-for-sale securities, gross unrealized loss for the quarter ending 2017-03-31 was -$1.05K.
- ALTIMMUNE, INC. available-for-sale securities, gross unrealized loss for the quarter ending 2016-03-31 was $0.00.
- ALTIMMUNE, INC. available-for-sale securities, gross unrealized loss for fiscal 2016 was $1.05K.
- ALTIMMUNE, INC. available-for-sale securities, gross unrealized loss for fiscal 2015 was $0.00.
- ALTIMMUNE, INC. available-for-sale securities, gross unrealized loss for fiscal 2014 was $0.00.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 3 month | Available-for-sale Securities, Gross Unrealized Loss 12 month |
|---|---|---|
| 2017-03-31 | -$1.05K 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $1.05K 10-K · filed 2017-03-14 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-03 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-14 | |
| 2014-12-31 | $0.00 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |